Aug 2026· International Journal for Global Academic & Scientific Research· 0 citations· 103 references
TL;DR
The results suggest that the use of AI to detect ASD is not yet ready for clinical use, and transparent reporting of validation, independent external cohorts, diverse datasets, and prospective testing of positive predictive value in realistic population prevalence should be the focus of future research.
Abstract
Autism spectrum disorder (ASD) is a developmental disorder that must be identified early but traditional diagnosis can be examiner-dependent, time-consuming and not accessible. This study included a dual bibliometric and systematic review on the evidence supporting the application of artificial intelligence (AI) tools in the detection of ASD according to PRISMA 2020 and SWiM guideline. A total of 41 empirical studies were identified after a search in the Scopus database. The studies were conducted between 2011 and 2026, in 11 data modalities, 7 algorithm families and 28 countries. The accuracy of the reports was between 68.18% and 100% with a median of 91%. Facial image research was the biggest modality, but all nine studies used the same public Kaggle dataset. Unstated validation designs occurred in 46% of studies, and 93% were at high risk of bias in the areas of patient selection and reference standards, and unclear flow and timing. Very high accuracy scores were massed in small, one cohort datasets, with population level studies obtaining significantly lower accuracy scores. But in general, there was only a small difference in median accuracy between the externally validated studies and the single-cohort studies (1.5 percentage points). The results suggest that the use of AI to detect ASD is not yet ready for clinical use. Transparent reporting of validation, independent external cohorts, diverse datasets, and prospective testing of positive predictive value in realistic population prevalence should be the focus of future research.
Artificial intelligence shows promise as a supportive tool for early screening, but current evidence supports its use as a complement to, rather than replacement for, clinical assessment.
Andrea Catalina Mahecha Ballesteros, Juanita Valeria García Bello, Eleaine Scarlet González Zuñiga et al.· Current Psychiatry Reports· 0 citations
It is argued that future early ASD detection systems should be developed as clinician-supervised decision-support tools rather than autonomous diagnostic instruments.
Wenhao Luo, Z. Yin, Jianbiao Dai· Diagnostics· 0 citations
A comprehensive review of recent advancements in ASD research, with particular emphasis on neuroimaging, artificial intelligence (AI), and machine learning (ML)-based diagnostic approaches, highlights the growing potential of AI-driven tools for supporting early ASD diagnosis and emphasizes the need for standardized pr...
Kuljeet Singh, Khushi Mogha, S. Moctar· Neurological Sciences· 0 citations
The need to develop large, well‐balanced datasets, the application of explainable AI techniques, standardization and regulatory guidelines for facilitating the clinical translation of ASD detection systems are suggested.
Anupama N, Chandrashekar M. Patil· International Journal of Dev...· 0 citations
AI and IoT technologies show considerable potential for supporting early identification of ASD‑related developmental differences, and the need for a Rwanda‑specific multimodal dataset and an explainable, affordable, privacy‑preserving, and externally validated AI‑IoT framework is highlighted.
G. Twesigye, E. Masabo, P. Bamurigire· African Journal Of Applied R...· 0 citations
This review evaluates the role of machine learning and deep learning approaches in improving ASD prediction, with a particular focus on two important yet relatively underexplored methodological components: data augmentation and feature selection.
Sahar Alkhaibari, Feng Dong· Health Care Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.